Mahalakshmi Gurumurthy

Summary

Country: UK

Publications

  1. doi request reprint The surgical management of complications of vulval lichen sclerosus
    Mahalakshmi Gurumurthy
    Clinical Research Fellow in Gynaecological Oncology, Ward 43, Aberdeen Royal Infirmary, Foresterhill Road, Aberdeen AB25 2ZN, UK
    Eur J Obstet Gynecol Reprod Biol 162:79-82. 2012
  2. doi request reprint Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study
    M Gurumurthy
    Gynaecological Oncology, Gynaecological Oncology Unit, University Hospital of Llandough, UK
    Scott Med J 58:88-94. 2013
  3. doi request reprint Management of vaginal intraepithelial neoplasia
    Mahalakshmi Gurumurthy
    Department of Gynecology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
    J Low Genit Tract Dis 16:306-12. 2012
  4. doi request reprint Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy
    M Gurumurthy
    Department of Obstetrics and Gynaecology, Arden Cancer Centre and Neonatal Unit, University Hospital Coventry and Warwickshire, Coventry, UK
    J Perinatol 29:63-5. 2009
  5. doi request reprint Case series of Zoon vulvitis
    Mahalakshmi Gurumurthy
    Department of Obstetrics and Gynaecology, Aberdeen Royal Infirmary, Aberdeen, UK
    J Low Genit Tract Dis 14:56-8. 2010
  6. doi request reprint An update on the management of uterine carcinosarcoma
    Mahalakshmi Gurumurthy
    Department of Gynecological Oncology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
    Obstet Gynecol Surv 66:710-6. 2011

Detail Information

Publications6

  1. doi request reprint The surgical management of complications of vulval lichen sclerosus
    Mahalakshmi Gurumurthy
    Clinical Research Fellow in Gynaecological Oncology, Ward 43, Aberdeen Royal Infirmary, Foresterhill Road, Aberdeen AB25 2ZN, UK
    Eur J Obstet Gynecol Reprod Biol 162:79-82. 2012
    ..To review the surgical procedures used to treat the complications of vulval lichen sclerosus at a single tertiary referral institution in north-east Scotland over a ten year period...
  2. doi request reprint Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study
    M Gurumurthy
    Gynaecological Oncology, Gynaecological Oncology Unit, University Hospital of Llandough, UK
    Scott Med J 58:88-94. 2013
    ..The incidence of uterine carcinosarcoma and factors associated with its survival are little known and this study helps to address this question for women residing in north-east Scotland...
  3. doi request reprint Management of vaginal intraepithelial neoplasia
    Mahalakshmi Gurumurthy
    Department of Gynecology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
    J Low Genit Tract Dis 16:306-12. 2012
    ..Vaginal intraepithelial neoplasia (VaIN) accounts for 0.4% of the lower genital tract intraepithelial disease. Various treatments have been reported often as small case series or reports...
  4. doi request reprint Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy
    M Gurumurthy
    Department of Obstetrics and Gynaecology, Arden Cancer Centre and Neonatal Unit, University Hospital Coventry and Warwickshire, Coventry, UK
    J Perinatol 29:63-5. 2009
    ..This is the second reported case on the use of gemcitabine for lung cancer in human pregnancy...
  5. doi request reprint Case series of Zoon vulvitis
    Mahalakshmi Gurumurthy
    Department of Obstetrics and Gynaecology, Aberdeen Royal Infirmary, Aberdeen, UK
    J Low Genit Tract Dis 14:56-8. 2010
    ..This series highlights 1 case that was refractory to all modalities of treatment and hence had to be managed surgically, which has only been reported once before...
  6. doi request reprint An update on the management of uterine carcinosarcoma
    Mahalakshmi Gurumurthy
    Department of Gynecological Oncology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
    Obstet Gynecol Surv 66:710-6. 2011
    ..In the future, the emergence of combination of chemotherapeutic agents with molecular-targeted agents may show promising results...